elagolix
Showing 1 - 24 of 24
Endometriosis Trial in Beijing (Elagolix, Elagolix )
Recruiting
- Endometriosis
- Elagolix
- Elagolix placebo
-
Beijing, Beijing, ChinaPeking University First Hospital
Oct 6, 2023
Endometriosis Trial in Beijing (Elagolix, Elagolix )
Recruiting
- Endometriosis
- Elagolix
- Elagolix placebo
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Dec 11, 2022
Endometriosis, Unexplained Infertility Trial in Winston-Salem (Elagolix, Oral Contraceptive)
Recruiting
- Endometriosis
- Unexplained Infertility
- Elagolix
- Oral Contraceptive
-
Winston-Salem, North CarolinaWake Forest Univesity Health Sciences
Dec 1, 2022
Heavy Uterine Bleeding, Uterine Fibroids Trial (Elagolix, Placebo, Estradiol/Norethindrone acetate (E2/NETA))
Completed
- Heavy Uterine Bleeding
- Uterine Fibroids
- Elagolix
- +4 more
- (no location specified)
Jul 9, 2021
Polycystic Ovary Syndrome Trial in Puerto Rico, United States (Elagolix, Placebo)
Completed
- Polycystic Ovary Syndrome
- Elagolix
- Placebo
-
Birmingham, Alabama
- +53 more
May 16, 2022
Heavy Uterine Bleeding, Uterine Fibroids Trial (Elagolix , Elagolix, 0.5 mg estradiol / 0.1 mg norethindrone acetate)
Completed
- Heavy Uterine Bleeding
- Uterine Fibroids
- Elagolix placebo
- +4 more
- (no location specified)
Jul 7, 2020
Endometriosis Trial in Puerto Rico, United States (Elagolix, Combined Oral Contraceptive (COC), Placebo for Elagolix)
Recruiting
- Endometriosis
- Elagolix
- +3 more
-
Anniston, Alabama
- +182 more
Jan 17, 2023
Uterine Fibroids, Heavy Menstrual Bleeding Trial in Canada, United States (Elagolix, Placebo for Estradiol/Norethindrone
Completed
- Uterine Fibroids
- Heavy Menstrual Bleeding
- Elagolix
- +3 more
-
Birmingham, Alabama
- +104 more
Jul 9, 2021
Heavy Menstrual Bleeding, Uterine Fibroids Trial in Puerto Rico, United States (Elagolix Placebo, E2/NETA, E2/NETA Placebo)
Active, not recruiting
- Heavy Menstrual Bleeding
- Uterine Fibroids
- Elagolix Placebo
- +3 more
-
Birmingham, Alabama
- +156 more
Jan 20, 2022
Endometriosis Trial in Canada, Puerto Rico, United States (Estradiol/Norethindrone Acetate, Placebo for Elagolix, Elagolix)
Active, not recruiting
- Endometriosis
- Estradiol/Norethindrone Acetate
- +3 more
-
Birmingham, Alabama
- +196 more
Feb 14, 2022
Uterine Fibroids, Heavy Menstrual Bleeding Trial in Canada, Puerto Rico, United States (Estradiol/Norethindrone Acetate,
Completed
- Uterine Fibroids
- Heavy Menstrual Bleeding
- Estradiol/Norethindrone Acetate
- Elagolix
-
Birmingham, Alabama
- +123 more
Jul 9, 2021
Uterine Fibroids, Heavy Menstrual Bleeding Trial in Canada, Puerto Rico, United States (Elagolix, Placebo for
Completed
- Uterine Fibroids
- Heavy Menstrual Bleeding
- Elagolix
- +3 more
-
Birmingham, Alabama
- +95 more
Jun 9, 2020
Endometriosis Trial in United States (elagolix, estradiol/norethindrone acetate (E2/NETA))
Terminated
- Endometriosis
- elagolix
- estradiol/norethindrone acetate (E2/NETA)
-
Anniston, Alabama
- +36 more
Nov 8, 2019
Endometriosis Trial (Leuprorelin Acetate Depot, Elagolix, Placebo to Elagolix)
Completed
- Endometriosis
- Leuprorelin Acetate Depot
- +3 more
- (no location specified)
Aug 9, 2018
Folliculogenesis Trial in Puerto Rico, United States (Elagolix, elagolix)
Completed
- Folliculogenesis
- Elagolix
- elagolix
-
Colorado Springs, Colorado
- +21 more
Jan 4, 2013